Literature DB >> 31561205

Changes of serum lipopolysaccharide, inflammatory factors, and cecal microbiota in obese rats with type 2 diabetes induced by Roux-en-Y gastric bypass.

Jiao Wu1, Peng-Bo Zhang2, Ze-Qiang Ren3, Fang Zhou4, Hui-Hui Hu4, Hong Zhang5, Kai-Kai Xue4, Pan Xu6, Xiao-Qing Shao6.   

Abstract

OBJECTIVES: Previous studies have shown that Roux-en-Y gastric bypass (RYGB) leads to rapid regression of obesity and type 2 diabetes (T2D). However, the underlying mechanism remains unclear. This study aimed to investigate the effect of RYGB on serum lipopolysaccharide (LPS), interleukin (IL)-1, IL-6, tumor necrosis factor alpha (TNF-α), and cecal microbiota in obese rats with T2D.
METHODS: Obese Sprague-Dawley rats with T2D were randomly divided into RYGB diabetes operation (DO; n = 8), diabetes sham operation (DS; n = 8), and diabetic control (DC; n = 8) groups. Healthy Sprague-Dawley rats were grouped as normal control (NC; n = 8). Fasting plasma glucose and body weight were measured. The levels of peripheral serum LPS, IL-1, IL-6, and TNF-α were measured by enzyme-linked immunosorbent assay. The rats were sacrificed 12 wk after operation. Subsequently, a superior mesenteric venous blood sample was taken to measure serum LPS levels by enzyme-linked immunosorbent assay. The cecal contents of the DO and DS groups were taken to extract metagenomic DNA per the genomic DNA standardization procedure. The V4 region of the 16 S rRNA was sequenced with the Illumina Hiseq sequencing platform to compare the structure and relative abundance of cecal microbiota between the DO and DS groups.
RESULTS: Twelve weeks after operation in the DO group, fasting plasma glucose and body weight showed a significant decrease (P < 0.05). Moreover, the levels of peripheral serum LPS, IL-1, IL-6, and TNF-α were obviously decreased (P < 0.05). A change in the LPS level of superior mesenteric venous blood also revealed a dramatic decrease (P < 0.05). Additionally, RYGB resulted in a shift of cecal microbiota in obese rats with T2D.
CONCLUSIONS: Hypoglycemic effects after RYGB may be associated with improved levels of LPS, IL-1, IL-6, and TNF-α. Changes in the structure of cecal microbiota may also play an important role.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Cecal microbiota; Inflammatory factors; Lipopolysaccharide; Roux-en-Y gastric bypass; Type 2 diabetes

Year:  2019        PMID: 31561205     DOI: 10.1016/j.nut.2019.110565

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  5 in total

1.  Simulating the Post-gastric Bypass Intestinal Microenvironment Uncovers a Barrier-Stabilizing Role for FXR.

Authors:  Mohammed K Hankir; Theresa Langseder; Ezgi Eyluel Bankoglu; Yalda Ghoreishi; Ulrich Dischinger; Max Kurlbaum; Matthias Kroiss; Christoph Otto; Carel W le Roux; Tulika Arora; Florian Seyfried; Nicolas Schlegel
Journal:  iScience       Date:  2020-11-05

2.  Impact of Metabolic Surgery on Gut Microbiota and Sera Metabolomic Patterns among Patients with Diabetes.

Authors:  Hsien-Hao Huang; Tzu-Lung Lin; Wei-Jei Lee; Shu-Chun Chen; Wei-Fan Lai; Chia-Chen Lu; Hsin-Chih Lai; Chih-Yen Chen
Journal:  Int J Mol Sci       Date:  2022-07-14       Impact factor: 6.208

3.  Leaky Gut as a Potential Culprit for the Paradoxical Dysglycemic Response to Gastric Bypass-Associated Ileal Microbiota.

Authors:  Mohammed K Hankir; Florian Seyfried; Isabel N Schellinger; Nicolas Schlegel; Tulika Arora
Journal:  Metabolites       Date:  2021-03-08

4.  A Potential Synbiotic Strategy for the Prevention of Type 2 Diabetes: Lactobacillus paracasei JY062 and Exopolysaccharide Isolated from Lactobacillus plantarum JY039.

Authors:  Jiayuan Zhao; Lihan Wang; Shasha Cheng; Yu Zhang; Mo Yang; Ruxue Fang; Hongxuan Li; Chaoxin Man; Yujun Jiang
Journal:  Nutrients       Date:  2022-01-16       Impact factor: 5.717

Review 5.  The Gut Microbiota Influenced by the Intake of Probiotics and Functional Foods with Prebiotics Can Sustain Wellness and Alleviate Certain Ailments like Gut-Inflammation and Colon-Cancer.

Authors:  Divakar Dahiya; Poonam Singh Nigam
Journal:  Microorganisms       Date:  2022-03-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.